Study a | Number of patients treated with AS-AQ | Country | Age range (months) | Target dose (mg/kg) for artesunate & amodiaquine | Manufacturer | Formulation | Supervision | Reference |
---|---|---|---|---|---|---|---|---|
Adjuik-2002 | 390 | Multicentric | 6-59 | 12 & 30 | Sanofi-Synthélabo & Parke-Davis | Loose NFDC | Full | [8] |
Anvikar-2012 b | 199 | India | 6-720 | 12 & 30 | Sanofi-Aventis | FDC | Full | [36] |
Barennes-2004 | 32 | Burkina Faso | 12-180 | 12 & 30 | Sanofi Winthrop AMO & Hoechst Marion Roussel | Loose NFDC | Full | [64] |
Bonnet-2007 | 110 | Guinea | 6-59 | 12 & 30 | Guilin Pharmaceutical & Parke-Davis | Loose NFDC | Full | [65] |
Brasseur-2009 b | 276 | Senegal | All ages | N/A | Sanofi-Aventis | Co-blistered NFDC | Full/partiale | [17] |
Bukirwa-2006 | 203 | Uganda | 12-120 | 12 & 25 | Sanofi-Aventis & Parke-Davis, Pfizer | Loose NFDC | Full | [66] |
Dorsey-2007 | 145 | Uganda | 12-120 | 12 & 25 | Sanofi-Aventis & Pfizer | Loose NFDC | Full | [67] |
Espié-2012 | 149 | DRC | 6-59 | 12 & 30 | Sanofi-Aventis | FDC | Full | [34] |
Faucher-2009 | 94 | Benin | 6-60 | 12 & 30 | Sanofi-Aventis | FDC | Partial | [68] |
Faye-2010 | 155 | Multicentric | >84 | N/A | Pfizer | Co-blistered NFDC | Full | [69] |
Gaye-2010b d | 129 | Senegal | 12-720 | 12 & 30 | Sanofi-Aventis | FDC | Full | [Unpublished] |
Grandesso-2003 d | 86 | Uganda | 6-59 | 12 & 30 | Sanofi & Park-Davis | Loose NFDC | Full | [Unpublished] |
Grandesso-2006 | 123 | Sierra Leone | 6-59 | 12 & 30 | Sanofi Winthrop AMO & Pfizer | Loose NFDC | Full | [44] |
Guthmann-2005 | 96 | Angola | 6-59 | 12 & 30 | Sanofi Winthrop & Parke Davis | Loose NFDC | Full | [70] |
Guthmann-2006 | 68 | Angola | 6-59 | 12 & 30 | Sanofi Winthrop & Parke Davis | Loose NFDC | Full | [71] |
Hamour-2005 | 71 | Sudan | 6-59 | 12 & 30 | Sanofi & Park-Davis | Loose NFDC | Full | [72] |
Hasugian-2007 | 93 | Indonesia | >12 | 12 & 30 | Guilin Pharmaceuticals & Aventis | Loose NFDC | Full | [6] |
Jullien-2010 | 27 | Kenya | 216-720 | N/A | Sanofi-Aventis | Co-blistered NFDC | Full | [73] |
Jullien-2010 | 24 | Kenya | 216-720 | 12 & 30 | Sanofi-Aventis | FDC | Full | [73] |
Juma-2005 d | 201 | Kenya | 6-59 | 12 & 30 | Sanofi-Aventis | Loose NFDC | Full | [Unpublished] |
Karema-2006 | 251 | Rwanda | 12-59 | 12 & 30 | Sanofi-Aventis | Loose NFDC | Full | [74] |
Kayentao-2009 | 128 | Mali | 6-59 | 12 & 30 | - | Co-blistered NFDC | Full | [75] |
Laminou-2011 d | 80 | Niger | 6-180 | 12 & 30 | Sanofi-Aventis | FDC | Partial | [Unpublished] |
MÃ¥rtensson-2005 | 202 | Tanzania | 6-59 | 12 & 30 | Mepha & Roussel | Loose NFDC | Full | [45] |
Menan-2012 d | 110 | Ivory Coast | 12-480 | 12 & 30 | Sanofi-Aventis | FDC | Full | [Unpublished] |
Menard-2008 | 332 | Madagascar | 6-180 | 12 & 30 | - | Loose NFDC | Full | [76] |
Ndiaye-2009 | 625 | Multicentric | All ages | 12 & 30 | Sanofi-Aventis | FDC | Full | [30] |
Ndiaye-2011 | 179 | Senegal | All ages | 12 & 30 | Sanofi-Aventis | FDC | Fullf | [32] |
Nikiema-2010 d | 527 | Burkina Faso | 6-120 | 12 & 30 | Sanofi-Aventis | FDC | Full | [Unpublished] |
Osorio-2007 | 37 | Columbia | 12-780 | 12 & 30 | Sanofi-Aventis | Loose NFDC | Full | [77] |
Rwagacondo-2004 | 157 | Rwanda | 6-59 | 12 & 30 | Dafra | Loose NFDC | Full | [11] |
Sagara-2012 | 230 | Mali | ≥6 | 12 & 30 | Sanofi-Aventis | Co-blistered NFDC | Full | [78] |
Sanofi-2013 d | 203 | Uganda | 6-59 | 12 & 30 | Sanofi-Aventis | FDC | Fullf | [Unpublished] |
Schramm-2013 | 147 | Liberia | 6-72 | 12 & 30 | Sanofi-Aventis | FDC | Full | [38] |
Sinou-2009 c | 13 | Congo | ≥192 | 12 & 30 | Saokim Pharmaceuticals Co | FDC | Full | [31] |
Sirima-2009 b | 441 | Burkina Faso | 6-59 | 12 & 30 | Sanofi-Aventis | Co-blistered NFDC | Full | [18] |
Sirima-2009 b | 437 | Burkina Faso | 6-59 | 12 & 30 | Sanofi-Aventis | FDC | Full | [18] |
Smithuis-2010 | 142 | Myanmar | >6 | 12 & 32/4 | Sanofi-Aventis | FDC | Partial | [7] |
Staedke-2004 | 130 | Uganda | 6-120 | 12 & 25 | Sanofi-Pfizer | Loose NFDC | Full | [79] |
Swarthout-2006 | 82 | DRC | 6-59 | 12 & 30 | Sanofi and Parke Davis & Pfizer | Loose NFDC | Full | [80] |
Temu-2010 d | 99 | Liberia | 6-60 | 12 & 30 | Sanofi-Aventis | FDC | Full | [Unpublished] |
The 4ABC StudyGroup-2011 | 981 | Multicentric | 6-59 | 12 & 30 | Sanofi-Aventis | FDC | Full | [15] |
Thwing-2009 | 101 | Kenya | 6-59 | 12 & 25 | Cosmo Pharmaceuticals & Pfizer | Loose NFDC | Full | [46] |
van den Broek-2006 | 87 | Congo | 6-59 | 12 & 30 | Cosmo Pharmaceuticals & Pfizer | Loose NFDC | Full | [81] |
Yeka-2005 | 714 | Uganda | ≥6 | 12 & 25 | Sanofi-Pfizer | Loose NFDC | Full | [82] |